baber/WOPTO huggingface dataset:
Patent CA-3084344-A1 (CA)
Inventor: FATTAL DAVID A
IPC: F21V8/00
Filed: 2017-12-18
Abstract: La présente invention concerne un affichage tête haute et un système d'affichage tête haute multivue qui fournissent une pluralité de vues différentes d'une image multivue combinée avec une vue d'un environnement physique vers un boîtier oculaire sous la forme d'une image combinée. L'affichage tête haute comprend un affichage basé sur des éléments à faisceaux multiples configuré de sorte à fournir les différentes vues de l'image multivue et un combinateur optique configuré de sorte à relayer les différentes vues vers le boîtier oculaire conjointement avec la vue de l'environnement physique. L'affichage basé sur des éléments à faisceaux multiples comprend un réseau d'éléments à faisceaux multiples configurés de sorte à fournir une pluralité de faisceaux lumineux directionnels ayant des directions correspondant à des directions de visualisation respectives de la pluralité de vues différentes et un réseau de modulateurs de lumière configurés de sorte à moduler la pluralité de faisceaux lumineux directionnels pour fournir l'image multivue.
Patent CA-3085953-A1 (CA)
Title: Compositions aqueuses comprenant des lipo-chito-oligosaccharides solubilises
Inventor: KELLAR KENNETH
IPC: A01P21/00
Filed: 2019-01-04
Abstract: La présente invention concerne des solutions aqueuses comprenant un ou plusieurs LCO solubilisés, ainsi que des procédés de désagglomération, d'émulsification et de solubilisation des LCO dans des solutions aqueuses.
Patent CA-3088059-A1 (CA)
Title: Conjugues anticorps-protac
Inventor: CHUANG SHIH-HSIEN
IPC: A61K47/68
Filed: 2019-01-09
Abstract: L'invention concerne un immunoconjugué présentant la formule Ab-[L1-(A-L2-B)m]n, (a) Ab étant un anticorps ou un fragment de liaison de ce dernier; (b) L1 et L2 étant chacun indépendamment un lieur, L1 et L2 étant identiques ou différents, et L1 étant relié à L2; (c) A étant un ligand/liant de protéine cible; (d) B étant un ligand/liant de ligase d'ubiquitine, et (e) n et m étant indépendamment des nombres entiers de 1 à 8. La protéine cible comprend une kinase, des récepteurs couplés à la protéine G, un facteur de transcription, des phosphatases et des membres de la superfamille RAS.
Patent CA-3090890-A1 (CA)
Title: Method and system for indicating the likelihood of a gastrointestinal condition
Inventor: MARSHALL BARRY JAMES
IPC: A61B7/00
Filed: 2018-12-13
Abstract: A system (10) for indicating the likelihood of a gastrointestinal (GI) condition by analysing bowel sounds is provided, the system (10) comprising a sound detector (12) configured to detect bowel sounds and generate a corresponding signal representative of the bowel sounds, a signal processor arranged to identify a plurality of bowel sound signals within the corresponding signal, each bowel sound signal representative of an individual bowel sound, wherein the system is arranged to identify at least one feature from each of the plurality of bowel sound signals so as to produce a collection of values for the same at least one feature, and determine at least one statistical distribution property of the collection of values, the statistical distribution property capable of at least assisting in providing an indication of the existence or non-existence of a GI condition, and wherein the system is further arranged to associate the at least one statistical distribution property with a reference parameter and determine the likelihood of the GI condition based on the association. A corresponding method is also provided.
Patent CA-3095743-A1 (CA)
Title: Fabrication methods, structures, and uses for passive radiative cooling
Inventor: FAIN ROMY M
IPC: F28F3/00
Filed: 2019-04-16
Abstract: Passive radiative cooling structures and apparatus manufactured with such cooling structures conserve energy needs. A flexible film transparent to visible light incorporates particles at a volume percentage larger than 25% so as to absorb and emit infrared radiation at wavelengths where Earth's atmosphere is transparent. Another film transparent to visible light is thin and flexible and configured to absorb and emit infrared radiation at wavelengths where Earth's atmosphere is transparent, wherein etchings or depositions are present on one or both surfaces. A high efficiency cooling structure has an emissive layer sandwiched between a waveguide layer and a thermal conductive layer. A solar cell panel is covered by a transparent passive radiative cooling film. A container housing an active cooling unit incorporates passive radiative cooling structures on one or more exterior surfaces.
Patent CA-3096946-A1 (CA)
Title: Diagnostic swab
Inventor: GILBERT BENOIT
IPC: G01N1/10
Filed: 2020-10-22
Abstract: A diagnostic swab comprises a monolithic molded body defining an elongated handle, and an adsorbing member at an end of the elongated handle, the adsorbing member having a plurality of lobes projecting from a shaft. A contour envelope of the adsorbing member defines a truncated prolate spheroid. The adsorbing member may have a junction plane. Halves of the adsorbing member separated by the junction plane each define a single-mold-cavity imprint surface.
Patent CA-3097582-A1 (CA)
Title: Modeles pour conduits de tympanostomie ou conduits de ventilation sous-annulaires et autres conduits medicaux et fluidiques
Inventor: BLACK NICOLE LEAH
IPC: A61F11/08
Filed: 2019-03-20
Abstract: L'invention concerne un système qui comprend un dispositif comprenant un conduit ayant une extrémité proximale ayant un rayon d'extrémité proximale, une extrémité distale opposée à l'extrémité proximale et ayant un rayon d'extrémité distale, une surface interne reliant l'extrémité proximale et l'extrémité distale et formant un angle proximal aux extrémités, la surface interne ayant des propriétés de surface, et une surface externe reliant les extrémités ; le rayon d'extrémité distale, le rayon d'extrémité proximale, l'angle distal, l'angle proximal, et les propriétés de surface de la surface interne sont sélectionnées pour : permettre l'entrée d'un premier matériau dans l'extrémité distale, le transport du premier matériau à travers le conduit le long de la surface interne vers l'extrémité proximale, et la sortie du premier matériau par l'extrémité proximale, et pour résister à l'entrée d'un second matériau dans l'extrémité proximale ; et la pression de Laplace pour le premier matériau étant inférieure à celle pour le second matériau.
Patent CA-3097665-A1 (CA)
Inventor: GUY GEOFFREY
IPC: A61K45/06
Filed: 2019-04-26
Abstract: Cannabidiol (CBD) is a cannabinoid designated chemically as 2-[(1R,6R)-3-Methyl-6-(1- methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol. Its empirical formula is C21H 30O2 and its molecular weight is 314.46. CBD is a cannabinoid that naturally occurs in the Cannabis sativa L. plant. CBD is a white to pale yellow crystalline solid which is insoluble in water and soluble in organic solvents. The present invention encompasses the surprising recognition that certain CBD preparations which are prepared from a botanical origin are more effective in treating diseases or disorders than preparations of CBD which are synthetic or purified to the extent no other impurities in the form of other cannabinoids are present. Prior CBD compositions have been prepared such that no psychoactive components, e.g., tetrahydrocannabinol (THC), remain in the final CBD preparation. Surprisingly, the absence of such minor impurities reduces the efficacy of CBD treatment. Such CBD preparations are characterized by chemical components and/or functional properties that distinguish them from prior CBD compositions. One or more components of the preparations described herein provide an unexpectedly synergistic effect when utilized in combination.
Patent CA-3100052-A1 (CA)
Title: Reparation de valve et interventions associees
Inventor: IVERSEN SVEN BENJAMIN
IPC: A61B17/04
Filed: 2019-06-05
Abstract: Des dispositifs et des ancrages de réparation de valve sont appropriés pour un procédé de réparation ou de simulation de la réparation d'une valve native d'un patient pendant une intervention non à cur ouvert. Le procédé comprend les étapes consistant à : fixer au moins deux éléments de fixation à la valve native ; appliquer une force auxdits au moins deux éléments de fixation de manière à ce qu'ils provoquent un effet de serrage sur au moins une partie de la valve native ; et fixer lesdits au moins deux éléments de fixation avec un ou plusieurs éléments d'ancrage de manière à ce que lesdits au moins deux éléments de fixation maintiennent l'effet de serrage.
Patent CA-3101293-A1 (CA)
Inventor: ROYALE VICTORIA J
IPC: A47L11/30
Filed: 2020-12-01
Abstract: ABSTRACT A handheld extraction cleaner includes a unitary body provided with a carry handle, and further provided with a supply tank, a recovery tank, and a suction source, all of which are carried on the unitary body. The various components of the extraction cleaner can be arranged for a balanced weight in hand. The supply and recovery tanks are configured to optimize the usable volume within the tanks, among other functions. A powered cleaning head including a removable brushroll is provided on the unitary body. Date Recue/Date Received 2020-12-01
Patent CA-3104619-A1 (CA)
Inventor: KUMAR BHAWESH
IPC: C09D123/10
Filed: 2019-05-29
Abstract: A polypropylene/thermoplastic vulcanizate insulative coating is disclosed. The coating is particularly suited for subsea applications, in particular providing insulation to joints in oil well pipes and other machinery. The coating exhibits mechanical properties superior to joint insulation coatings known in the art, especially in combination with other insulation coatings.
Patent CA-3111914-A1 (CA)
Title: Methods of continuous cell culture
Inventor: YIN JIN
IPC: C12M1/04
Filed: 2019-08-28
Abstract: The present disclosure provides, among other things, continuous culture methods for producing a cell product, e.g., a recombinant protein, e.g., a glycoprotein, e.g., an antibody agent or a fusion protein. In some instances, methods herein allow large-scale production of a recombinant protein using continuous culture methods. The present disclosure identifies and addresses a problem with current continuous cell culture techniques in that at large-scale culture of certain cells have insufficient viable cell concentrations and impaired cell viability. The present disclosure provides, in part, methods and systems for large-scale continuous culture of shear-sensitive cells.
Patent CA-3112219-A1 (CA)
Title: Procede d'extraction de bio-huile a partir de biomasse algale
Inventor: DE ANGELIS ALBERTO RENATO
IPC: C10L1/02
Filed: 2019-09-09
Abstract: La présente invention a pour objet un procédé d'extraction de bio-huile à partir de biomasse algale, en particulier de microalgues huileuses, à l'aide de solvants constitués de solvants eutectiques profonds (DBS), capable de produire une bio-huile avec une faible teneur en phospholipides et en sels inorganiques, principalement du chlorure de sodium.
Patent CA-3113322-A1 (CA)
Inventor: INTRATOR NATHAN
IPC: A61B5/375
Filed: 2019-09-18
Abstract: L'invention concerne des méthodes et des systèmes permettant d'optimiser une stimulation cérébrale invasive et non invasive. Dans un mode de réalisation particulier, l'invention concerne des méthodes et des systèmes pour une approche combinatoire et itérative destinée à modifier un comportement, une stimulation cérébrale profonde (DBS) et d'autres thérapies de stimulation cérébrale étant mises en uvre en association avec la surveillance de l'activité cérébrale d'un individu en vue d'optimiser l'efficacité de l'approche combinatoire destinée à modifier le comportement. Les méthodes décrites dans la description sont itératives et les systèmes décrits dans la description sont utilisés de manière itérative. Dans un mode de réalisation particulier, la modification du comportement fournit une thérapie pour un individu en ayant besoin.
Patent CA-3113798-A1 (CA)
Inventor: ABBASIAN MAHAN
IPC: C12N15/13
Filed: 2019-09-24
Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-a (SIRPa) and modulate the activity of SIRPa.
Patent CA-3114008-A1 (CA)
Title: Multi-surface traction sling
Inventor: NELSON ALSIE
IPC: A43C15/12
Filed: 2021-04-01
Abstract: A multi-surface and traction sling configured to be stretched over shoes or boots that does not utilize any metal or hard surfaced traction elements, including spikes, cleats or springs, on the bottom surface. The multi-surface traction sling is composed of a generally flexible and stretchable sling and a traction sole that is much less flexible and possesses a high coefficient of friction.
Patent CA-3115037-A1 (CA)
Title: Introducer devices and methods of use thereof
Inventor: VIQUEZ JOSE PABLO
IPC: A61B17/34
Filed: 2019-10-02
Abstract: Aspects of the present disclosure are directed to a medical implant introducer (100) and methods of its use. The introducer (100) may include a handle (120), an implant-holding cavity disposed distally from the handle (120), a fluid supply conduit (122) fluidly coupled to an interior portion of the implant-holding cavity, and a distal nozzle (110) having a proximal portion, a distal portion, a middle portion in between the proximal portion and the distal portion, the middle portion having a tapered profile such that the proximal portion is larger than the distal portion, and a distal opening (112), wherein an implant in the implant-holding cavity may be expelled from the introducer (100) through the distal opening (112).
Patent CA-3115124-A1 (CA)
Inventor: MCBURNETT MICHAEL
IPC: G06F21/60
Filed: 2021-04-14
Abstract: Techniques for risk evaluation include receiving, from a requesting entity, a request for monitoring target entities specifying a first identifier associated with each target entity and target entity information. The system generates a second identifier and a third identifier for each target entity and stores a mapping of the second identifiers to the first identifiers and the third identifiers, preventing the second identifiers from being provided to the requesting entity. The system monitors a periodically updated data set and determines risk metrics for the target entities, comparing each risk metric to a threshold value to identify target entities whose risk data indicates an insider threat. The system generates a third identifier for the identified target entities and provides the third identifiers to the requesting entity. Responsive to a request for a corresponding first identifier, the system identifies and provides the first and third identifiers to the requesting entity.
Patent CA-3115351-A1 (CA)
Inventor: ALDERSON FARAZ A
IPC: A01P1/00
Filed: 2019-12-04
Abstract: Antimicrobial compositions comprising at least one C3-C5 N-alkyl-gamma-butyrolactam, e.g. N- butyl-gamma-butyrolactam, are provided. Methods of using C3-C5 N-alkyl-gamma-butyrolactam compounds and compositions to reduce the population of microbes on a surface are also provided.
Patent CA-3115834-A1 (CA)
Title: Biocrypt digital wallet
Inventor: QIAN YUMING
IPC: G06F16/27
Filed: 2019-10-11
Abstract: A device and method for using biometric technologies to ensure secure transactions using blockchain technology are disclosed. The embodiments described mitigate at least some security related problems in conventional blockchain digital wallets, particularly those that cannot reliably authenticate user identity. The present disclosure presents a method and apparatus for using authentication and data protection for implementing a blockchain offline wallet using biometrics.
Patent CA-3117916-A1 (CA)
Inventor: QUIBELL MARTIN
IPC: C07D211/10
Filed: 2019-11-22
Abstract: The present invention relates to a compound of formula (Ia), or a pharmaceutically acceptable salt or hydrate thereof, wherein: the group X-Y is -NHSO2- or -SO2NH-; R1 is H or alkyl; R2 is selected from COOH and a tetrazolyl group; R3 is selected from H, Cl and alkyl; R4 is selected from H, Cl and F; R5 is selected from H, alkyl, alkynyl, alkenyl, haloalkyl, SO2-alkyl, Cl, alkoxy, OH, CN, hydroxyalkyl, alkylthio, heteroaryl, cycloalkyl, heterocycloalkyl and haloalkoxy; R6 is H; R7 is selected from H, CN, haloalkyl, Cl, F, SO2-alkyl, SO2NR13R14, optionally substituted heteroaryl and alkyl; R8 is selected from H, alkyl, haloalkyl and halo; R9 is H, C1-C3-alkyl, or halo; R10 and R11, together with the nitrogen to which they are attached, form an azepanyl group, wherein (a) said azepanyl group is substituted by one or more substituents, or (b) one or two carbons in said azepanyl group are replaced by a group selected from O, NH, S and CO, and said azepanyl group is optionally further substituted; or R10 and R11, together with the nitrogen to which they are attached, form an azetidinyl, pyrrolidinyl or piperidinyl group wherein (a) said azetidinyl, pyrrolidinyl or piperidinyl group is substituted by one or more substituents, or (b) one or two carbons in said azetidinyl, pyrrolidinyl or piperidinyl group are replaced by a group selected from NH, S and CO; or R10 and R11, together with the nitrogen to which they are attached, form an 8, 9 or 10-membered bicyclic heterocycloalkyl group, wherein one or two carbons in the bicyclic heterocycloalkyl ring are optionally replaced by a group selected from O, NH, S and CO, and said bicyclic heterocycloalkyl group is optionally substituted; or R10 and R11, together with the nitrogen to which they are attached, form a 6 to 12-membered bicyclic group containing a spirocyclic carbon atom, wherein one or two carbons in the bicyclic group are optionally replaced by a group selected from O, NH, S and CO, and said bicyclic group is optionally substituted, or said bicyclic group is optionally fused to a 5 or 6-membered aryl or heteroaryl group; R13 and R14 are each independently H or alkyl. Further aspects of the invention relate to such compounds for use in the field of immune-oncology and related applications.
Patent CA-3118949-A1 (CA)
Title: Novel amorphous active pharmaceutical ingredients
Inventor: FRYKSTRAND ANGSTROM SARA
IPC: A61K47/02
Filed: 2019-11-06
Abstract: The present invention is directed to a solid and substantially amorphous active pharmaceutical ingredient, to an oral pharmaceutical formulation comprising said substantially amorphous active pharmaceutical ingredient, as well as to a method for the manufacture of the same. The invention is also directed to a particulate anhydrous and substantially amorphous mesoporous magnesium carbonate(MMC), to a method for the manufacture thereof, and the use of said particulate anhydrous and substantially amorphous mesoporous magnesium carbonate (MMC)to stabilize an active pharmaceutical ingredient (API).
Patent CA-3121029-A1 (CA)
Inventor: WEBER TOBIAS
IPC: H02K41/03
Filed: 2019-11-26
Abstract: L'invention un dispositif et un procédé permettant d'entraîner au moins un mécanisme de déplacement (200, 513, 514), ledit élément de déplacement (200, 513, 514) présentant au moins un deuxième générateur de champ magnétique, ledit mécanisme de déplacement (200) pouvant se déplacer sur une surface d'entraînement (510) ayant plusieurs secteurs, les secteurs (501) présentant des générateurs de champ magnétique destinés à générer au moins un champ magnétique, une planification de trajectoire pour l'élément de déplacement (200) étant exécutée sur la surface d'entraînement (510), d'un point de départ (507) à un point cible (508), au moins un graphe (503) comportant des nuds (505) et des arêtes (504) étant utilisés pour la planification de trajectoire, un chemin (511) étant déterminé pour l'élément de déplacement (200) sur la base du graphe (503).
Patent CA-3124055-A1 (CA)
Inventor: FARRELL DAVID J
IPC: A61L29/14
Filed: 2019-12-12
Abstract: Hydrophilic coatings including a polymer matrix having voids wherein microparticles having a lubricious liquid are located within the voids.
Patent CA-3124229-A1 (CA)
Inventor: BRAUN TONY
IPC: G04B17/28
Filed: 2021-07-12
Abstract: The present invention concerns an adjustable lever (100) of a tourbillon mechanism for stopping at least one tourbillon unit (200). Said adjustable lever (100) comprising at least one first member (110) configured to be actuated, at least one second member (120) configured to actuate at least one brake element (240) and at least one adjustment member (130) configured to adjust a position of said at least one second member (120) via a method of adjustment.
Patent CA-3125121-A1 (CA)
Inventor: ROBERT-BEAUDOIN DOMINIQUE
IPC: A47K3/36
Filed: 2021-07-20
Abstract: Il est décrit un ensemble darticulation comprenant un premier corps articulé, un ensemble daxes de pivotement et un deuxième corps articulé. Le premier corps articulé comprend un canal. Lensemble daxes de pivotement comprend un corps de goupille configuré dans le but de venir en prise de manière coulissante avec le canal. Lensemble daxes de pivotement peut être traduit au sein du canal et fixé de manière ajustable le long du canal. Un corps de goupille sétendant vers le bas fait partie du corps de goupille. Le deuxième corps articulé comprend une ouverture de goupille configurée dans le but de recevoir la goupille de manière coopérative. Le premier corps articulé et le deuxième corps articulé sont agencés pour pivoter articulairement selon un axe darticulation défini par laxe lorsque laxe est reçu dans louverture de laxe. Le corps de goupille peut comporter une ouverture de corps daxe agencée pour recevoir une attache dalignement telle que le corps daxe puisse être basculé par rapport au premier corps articulé.
Patent CA-3126630-A1 (CA)
Title: Inhalation chamber
Inventor: BRICHET-BILLET ETIENNE
IPC: A61M16/06
Filed: 2020-01-14
Abstract: The present invention concerns an inhalation chamber (1) comprising a body (10) having an inlet orifice suitable for being connected to the outlet end piece of a metering aerosol, and an outlet orifice (12) suitable for being connected to a mouthpiece (30) or a mask (3) to be applied on the face of a patient, and a support (13) suitable for receiving the outlet end piece (20) of the metering aerosol (2), the support (13) opening into the inlet orifice, characterised in that the axis (X) of the inlet orifice this is not co-linear with the axis (Y) of the outlet orifice and in that the support is mounted on the body (10) to pivot about the axis (X) of the inlet orifice.
Patent CA-3128142-A1 (CA)
Inventor: BEALE GARY
IPC: A61B18/18
Filed: 2020-01-29
Abstract: A microwave antenna apparatus comprises a radiating element configured to perform a treatment, the treatment comprising heating a volume of tissue using microwave radiation emitted from the radiating element; a cooling structure arranged for flowing a coolant through at least one lumen of the cooling structure during the treatment; and a controller configured to control the flow of coolant such as to provide a first flow rate of coolant through the at least one lumen during a first period of the treatment and to provide a second, different flow rate of coolant through the at least one lumen during a second, later period of the treatment.
Patent CA-3129150-A1 (CA)
Title: Interface message test method and device, computer equipment and storage medium
Inventor: SUN YANG
IPC: G06F11/36
Filed: 2021-08-27
Abstract: The present invention discloses to a message conversion method, apparatus, computer device, and storage medium. The method comprises: obtaining actual interface message, the actual interface message carries the current interface identity; obtaining target benchmark interface message according to the current interface identity; determining differential node set according to the actual interface message and the target benchmark interface message; and determining interface message test result according to node value corresponding to the differential node in the differential node set, the interface message test result is used to determine the correctness of the actual interface message. This method can test the interface message comprehensively and improve accuracy of interface message test.